Medtronic (MDT) Shares Outstanding (Weighted Average) (2013 - 2026)

Medtronic has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $1.3 billion for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $1.3 billion, changed 0.36% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.3 billion (changed 0.36% YoY), and the FY2025 annual result was $1.3 billion, down 3.17% from the prior year.
• Shares Outstanding (Weighted Average) came in at $1.3 billion for Q1 2026 at Medtronic, roughly flat from $1.3 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2022 to a low of $1.3 billion in Q3 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.3 billion (2022), against an average of $1.3 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) gained 0.08% in 2023 and dropped 3.23% in 2025, its largest moves.
• Medtronic's Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then increased by 0.07% to $1.3 billion in 2023, then decreased by 3.13% to $1.3 billion in 2024, then declined by 0.51% to $1.3 billion in 2025, then grew by 0.01% to $1.3 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.